Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, California; Department of Hematology, University Hospital and University Zurich, Zurich, Switzerland.
Division of Pediatric Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, California.
Biol Blood Marrow Transplant. 2019 Dec;25(12):2338-2349. doi: 10.1016/j.bbmt.2019.08.001. Epub 2019 Aug 12.
Graft-versus-host disease (GVHD) remains a major complication of allogeneic hematopoietic cell transplantation. Acute GVHD (aGVHD) results from direct damage by donor T cells, whereas the biology of chronic GVHD (cGVHD) with its autoimmune-like manifestations remains poorly understood, mainly because of the paucity of representative preclinical models. We examined over an extended time period 7 MHC-matched, minor antigen-mismatched mouse models for development of cGVHD. Development and manifestations of cGVHD were determined by a combination of MHC allele type and recipient strain, with BALB recipients being the most susceptible. The C57BL/6 into BALB.B combination most closely modeled the human syndrome. In this strain combination moderate aGVHD was observed and BALB.B survivors developed overt cGVHD at 6 to 12 months affecting eyes, skin, and liver. Naïve CD4 cells caused this syndrome as no significant pathology was induced by grafts composed of purified hematopoietic stem cells (HSCs) or HSC plus effector memory CD4 or CD8 cells. Furthermore, co-transferred naïve and effector memory CD4 T cells demonstrated differential homing patterns and locations of persistence. No clear association with donor Th17 cells and the phenotype of aGVHD or cGVHD was observed in this model. Donor CD4 cells caused injury to medullary thymic epithelial cells, a key population responsible for negative T cell selection, suggesting that impaired thymic selection was an underlying cause of the cGVHD syndrome. In conclusion, we report for the first time that the C57BL/6 into BALB.B combination is a representative model of cGVHD that evolves from immunologic events during the early post-transplant period.
移植物抗宿主病(GVHD)仍然是异基因造血细胞移植的主要并发症。急性 GVHD(aGVHD)是由供体 T 细胞直接损伤引起的,而慢性 GVHD(cGVHD)的生物学及其自身免疫样表现仍知之甚少,主要是因为缺乏有代表性的临床前模型。我们在较长时间内检查了 7 种 MHC 匹配、次要抗原不匹配的小鼠模型,以研究 cGVHD 的发展。cGVHD 的发展和表现是由 MHC 等位基因类型和受体品系共同决定的,BALB 受体最易受影响。C57BL/6 到 BALB.B 的组合最接近人类综合征。在这种品系组合中,观察到中度 aGVHD,并且 BALB.B 幸存者在 6 至 12 个月时出现明显的 cGVHD,影响眼睛、皮肤和肝脏。幼稚 CD4 细胞引起这种综合征,因为由纯化造血干细胞(HSCs)或 HSC 加效应记忆 CD4 或 CD8 细胞组成的移植物不会引起明显的病理学。此外,共转导的幼稚和效应记忆 CD4 T 细胞表现出不同的归巢模式和持续存在的位置。在这种模型中,没有观察到供体 Th17 细胞与 aGVHD 或 cGVHD 的表型有明显关联。供体 CD4 细胞对骨髓胸腺上皮细胞造成损伤,这是负责负 T 细胞选择的关键群体,这表明胸腺选择受损是 cGVHD 综合征的一个潜在原因。总之,我们首次报道 C57BL/6 到 BALB.B 的组合是一种从移植后早期免疫事件发展而来的 cGVHD 代表性模型。